Paid Clinical Trials Fargo

Discover 186 paid clinical trials in Fargo. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 186

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Fargo, Detroit Lakes, Fosston, Park Rapidsshow 638 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Recruiting

Sponsor:

NRG Oncology

Location:

Fargo, Detroit Lakes, Fergus Falls, Fosstonshow 117 more

Code:

NCT05080673

Conditions

Adenocarcinoma of the Colon

Adenocarcinoma of the Rectum

Eligibility Criteria

Sex: All

Age: 50 - 70

Healthy Volunteers: Not accepted

Interventions

5-year and 10 Year Surveillance Colonoscopy after Qualifying Colonoscopy

Comparing Two Methods to Follow Patients With Pancreatic Cysts

Recruiting

Sponsor:

ECOG-ACRIN Cancer Research Group

Location:

Fargo, Thief River Falls, Bemidji, Bismarckshow 224 more

Code:

NCT04239573

Conditions

Pancreatic Carcinoma

Eligibility Criteria

Sex: All

Age: 50 - 70+

Healthy Volunteers: Not accepted

Interventions

Computed Tomography

Endoscopic Ultrasound

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Recruiting

PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Fargo, Winnipeg, Sioux Falls, Rochestershow 64 more

Code:

NCT03486873

Conditions

Solid Tumors

Hematologic Malignancies

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

Standard of Care (SOC)

Lenvatinib

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Fargo, Detroit Lakes, Fergus Falls, Fosstonshow 351 more

Code:

NCT03866382

Conditions

Bladder Adenocarcinoma

Bladder Clear Cell Adenocarcinoma

Bladder Mixed Adenocarcinoma

Bladder Neuroendocrine Carcinoma

Bladder Small Cell Neuroendocrine Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Scan

Cabozantinib S-malate

Computed Tomography

Echocardiography

Study of SFA002 in Patients With Mild to Moderate Psoriasis Plaques

Recruiting

PHASE1

Sponsor:

SFA Therapeutics

Location:

Fargo, Baltimore, Philadelphia, Webstershow 1 more

Code:

NCT05642182

Conditions

Psoriasis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Drug (SFA002) Vitamin D, Magnesium

Drug (SFA002) Vitamin D, Magnesium and Propionate

A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream

Recruiting

PHASE1

Sponsor:

Incyte Corporation

Location:

Fargo, Auburn Hills, Indianapolis, Troyshow 17 more

Code:

NCT06213831

Conditions

Prurigo Nodularis

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Ruxolitinib Cream 1.5%

A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)

Recruiting

PHASE3

Sponsor:

Melt Pharmaceuticals

Location:

Fargo, W. Fargo, Alexandria, Sioux Fallsshow 8 more

Code:

NCT06383273

Conditions

Cataract

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

MELT-300 sublingual tablet

Midalozam sublingual tablet

Placebo sublingual tablet

MILD® Percutaneous Image-Guided Lumbar Decompression: a Medicare Claims Study

Recruiting

Sponsor:

Vertos Medical, Inc.

Location:

Fargo, Grand Forks, Bismarck, Mason Cityshow 944 more

Code:

NCT03072927

Conditions

Lumbar Spinal Stenosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MILD

Interspinous Process Decompression

A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults with Chronic Inducible Urticaria

Recruiting

PHASE2

Sponsor:

Evommune, Inc.

Location:

Fargo, Indianapolis, Oklahoma City, New Albanyshow 12 more

Code:

NCT06603220

Conditions

Chronic Inducible Urticaria

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Oral EVO756